Therapeutic outcomes of 68 cases with oropharyngeal squamous cell carcinoma referring to UICC version 7 and 8

Akihiro Tamae, Masanobu Sato, Hidetaka Yamamoto, Teppei Noda, Kazuo Nishiyama, Koichiro Nakashima, Ryuji Yasumatsu

研究成果: Contribution to journalArticle査読

抄録

We retrospectively reviewed the records of 68 patients with oropharyngeal squamous cell carcinoma who had undergone initial treatment in the Department of Otolaryngology, Head and Neck Surgery, Hamanomachi Hospital between 2009 and 2017. We compared therapeutic outcomes of p16-positive with p16-negative cases, referring to Unio Internationalis Contra Cancrum(UICC)diagnostic criteria version 7 and 8. Of 68(58.5%)patients, 38 were diagnosed as p16-positive. The 3-year disease-specific survival rate of all patients, p16-positive, and p16-negative patients were 78.5%, 74.1%, and 84.7%, respectively. Referring to UICC version 8, the 3-year disease-specific survival rate(3DSS)of p16-negative patients in each clinical stage was stage Ⅱ: 100%, stageⅢ: 66.7%, and stage Ⅳa: 70.6%, whereas 3DSS of p16-positive patients was stage I: 93.8%, stageⅡ: 83.3%, stageⅢ: 77.1%, and stage Ⅳ: 0%.

本文言語英語
ページ(範囲)59-63
ページ数5
ジャーナルJapanese Journal of Head and Neck Cancer
46
1
DOI
出版ステータス出版済み - 2020

All Science Journal Classification (ASJC) codes

  • 耳鼻咽喉科学
  • 腫瘍学

フィンガープリント

「Therapeutic outcomes of 68 cases with oropharyngeal squamous cell carcinoma referring to UICC version 7 and 8」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル